Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica

Overview

The aim of this study is to evaluate a simple and rapid method in order to better define and treat Polymyalgia Rheumatica by measuring levels of muscle achiness and pain with a blood pressure cuff.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: August 2013

Detailed Description

This study is being conducted to evaluate a method for the quantifying of the proximal tenderness in patients with presumed diagnosis of Polymyalgia Rheumatica(PMR)using the measurements of pain thresholds(in both upper and lower arms) by the use of a standard blood pressure cuff. At the present time the diagnosis of PMR is based upon four classic criteria, History of sudden onset symmetric painful proximal myopathy, Physical demonstrating proximal tenderness without loss of motion passively, Laboratory evidence of significant inflammation: ESR>50 and treatment with a rapidly beneficial response to low dose prednisone. While the history, laboratory findings, and the response to prednisone are easily documented, the complaint of tenderness and the physical response to that tenderness is difficult to define and quantitate. By better quantifying the tenderness and the physical response to that tenderness will, it is hoped, lead to more rapid diagnosis as well as improved approach to treatment. Three groups of patients will be studied. Each patient, after written informed consent and procedure statement, will have pain threshold measurements taken and recorded by standard blood pressure cuff 4 times: one each on the lower and upper arms. The blood pressure cuff will be inflated to the level of maximum pain, then deflated, recording the maximum pain level. Absolute numbers will be used for each measurement. Blood pressure will not be recorded. This study is an attempt to add definition to the diagnosis of Polymyalgia Rheumatica with a both simple and rapid office exam.

Arms, Groups and Cohorts

  • Subjects with Polymyalgia Rheumatica
    • 50 subjects with Polymyalgia Rheumatica, both acute and chronic
  • Subjects w/o Polymyalgia Rheumatica
    • 50 subjects with Rheumatic Disease other than polymyalgia Rheumatica
  • Subjects w/o Rheumatic Disease
    • 50-Non Rheumatic disease subjects

Clinical Trial Outcome Measures

Primary Measures

  • To define whether the measurement of proximal arm tenderness can be used to diagnose and treat patients with Polymyalgia Rheumatica
    • Time Frame: One to two visits each subject

Secondary Measures

  • Assessing the ease of measuring proximal arm tenderness
    • Time Frame: One to two visits each subject

Participating in This Clinical Trial

Inclusion Criteria

  • Patients signing Informed Consent Exclusion Criteria:

  • Patients less than 50 years old

Gender Eligibility: All

Minimum Age: 50 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Lahey Clinic
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Gerald S. Harris, M.D., Principal Investigator, Lahey Clinic, Inc. Arlingtion

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.